Navigation Links
Thomas Dubinski joins Dyadic as Chief Financial Officer
Date:7/30/2014

JUPITER, Fla., July 30, 2014 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), is a global biotechnology company whose patented and proprietary technologies are used to discover, develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today the appointment of Thomas "Tom" Dubinski as Vice President and Chief Financial Officer. Tom will be responsible for leading the financial and information technology operations for Dyadic and will succeed Michael Faby effective August 4, 2014.

Logo - http://photos.prnewswire.com/prnh/20110621/CL06708LOGO

Prior to joining Dyadic, Tom held senior management positions at Fortune 500 businesses with global operations. From 2012 to 2014, Tom served as a management consultant at CFO Solutions. Tom previously served as Finance Officer for Walgreens Infusion Services where he was responsible for the finance function of a division with approximately $1 billion in revenue, and he has also held other senior positions within Walgreens corporate finance from 2007 to 2011. Prior to Walgreens, Tom was Director of Finance for Novartis Medical Nutrition from 2005 to 2006 and Chief Financial Officer of Metal Technology Solutions, a private manufacturer of precision metal components, from 2002 to 2004. Tom is also an 18 year veteran of Abbott Laboratories, where he had senior finance leadership roles in the areas of commercial operations, product development and manufacturing from 1984 to 2002.

Mark Emalfarb, Chief Executive Officer said, "I strongly believe Tom possesses the skills to help us build upon our existing infrastructure to ensure financial accuracy as we embark upon becoming an SEC reporting company.  He also has significant int
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors
2. ISPE Names Dr. Thomas Zimmer as Vice President of European Operations
3. Ohr Pharmaceutical Appoints Thomas M. Riedhammer To Board Of Directors
4. NuView Life Sciences and Thomas Jefferson University Sign Agreement for Exclusive Development and Commercialization Rights to Novel Prostate Cancer Diagnostic
5. Thomas Elsaesser and Horst Weller receive the Julius Springer Prize for Applied Physics 2012
6. Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist
7. Dr. Neal Rouzier Joins BioTE Medical
8. Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member
9. Dr. Iffath Abbasi Hoskins Joins Americords Advisory Board
10. Yale Cancer Center Joins OncLive's Strategic Alliance Partnership
11. Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... YORK , Feb. 26, 2015 S&P ... Factual Stock Report coverage on MabVax Therapeutics Holdings ... (MBVX) is a clinical stage biotechnology company focused on ... unmet medical needs in the treatment of cancer. MabVax ... based on the protective immune responses generated by patients ...
(Date:2/26/2015)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... develops and commercializes proprietary technologies and products for advanced ... for the fiscal first quarter ended December  31, 2014. ... dollars (CAD), unless otherwise stated. "During ... from our existing customers and add to our sales ...
(Date:2/26/2015)... Feb. 26, 2015 Protiviti ( www.protiviti.com ), ... of the Governance Portal , designed to increase ... compliance (GRC) tasks across multiple business units and projects. ... help customers better align their controls with the COSO ... ) requirements. In response to client feedback, Protiviti has ...
(Date:2/26/2015)... Woodbridge, NJ (PRWEB) February 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... in a trade secrets lawsuit against Genewiz Inc. in ... illegally obtained and utilized GenScript’s trade secrets, and that ... The court entered an order denying motions for ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... Feb. 27 Tengion Inc., a clinical,stage regenerative ... neo-vessels, announced today that it has appointed Jeff,Randall ... more than 25 years,experience as a senior- level ... to Tengion, including expertise in the healthcare, device,manufacturing ...
... CHARLESTON, S.C., Feb. 27 JSJ Pharmaceuticals ... new aesthetic division,Vitivia(TM). Vitivia(TM) will focus on ... of JSJ Pharmaceuticals in the development of,science-based, ... will be its Pro:Vitamin line.,Topical vitamins have ...
... February 27 Debiopharm Group,(Debiopharm), a global ... conditions and particularly oncology, today,announced the establishment ... Ecole,Polytechnique Federale de Lausanne (EPFL), focusing on ... 2.5 million endowment, the objective,of the chair ...
Cached Biology Technology:Tengion Appoints Jeff Randall to Board of Directors 2JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM) 2Debiopharm and EPFL Establish an Oncology Chair 2
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... CEO Conference on January 29 th at 10:30 ... CEO of NXT-ID will present and host a live ... wallet and its full suite of biometric technologies. Investors ...
(Date:1/22/2015)... 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased ... State of Washington,s Department of Licensing, ... and central issuance system for driver,s licenses and identification cards ... planning and development will start in January 2015, with enrollment ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... York, NY) The Parkinson,s Disease Foundation (PDF) is pleased ... the potential of individualized stem cell therapy to treat ... research of Marina Emborg, M.D., Ph.D., and Su-Chun Zhang, ... This award was chosen as part of PDF,s ...
... DCGeorgetown University Medical Center and Oak Ridge ... the institutions that formalizes their research relationship ... in the areas of structural biology, systems ... The Comprehensive Research and Development Agreement ...
... 23, 2008 -- Eight Oak Ridge National Laboratory nanomanufacturing ... Department of Energy,s Industrial Technologies Program. The awards, ... $1.6 million to partners, are the result of a ... The awards are for the following projects: ...
Cached Biology News:Parkinson's Disease Foundation announces award of $150,000 2GUMC and Oak Ridge National Labs announce unique research partnership 2GUMC and Oak Ridge National Labs announce unique research partnership 3ORNL nanotechnologies big winners in DOE call 2ORNL nanotechnologies big winners in DOE call 3